62 related articles for article (PubMed ID: 11877066)
1. [Clinical significance of hemostatic molecular markers in acute leukemia].
Wu F; Wang X; Qu B; Huang X; Wang H
Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):141-4. PubMed ID: 11877066
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of hemostatic molecular markers expression in patients with cancer].
Wu F; Qu B; Wang XF; Yang CM; Wang HL
Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):837-40. PubMed ID: 15634544
[TBL] [Abstract][Full Text] [Related]
3. [A study of tissue factor expression and hemostatic molecular markers in patients with acute promyelocytic leukemia].
Wu F; Wang X; Zhao W; Wang H; Shen Z
Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):36-9. PubMed ID: 11798557
[TBL] [Abstract][Full Text] [Related]
4. Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes.
Vila V; Martínez-Sales V; Réganon E; Peris E; Perez F; Ruano M; Aznar J
Haematologica; 2001 Jul; 86(7):729-34. PubMed ID: 11454528
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of plasma tissue factor pathway and urokinase-type plasminogen activator system in cancer patients.
Zhao W; Wang X; Qu B; Huang X; Wang H
Chin Med J (Engl); 2002 May; 115(5):702-4. PubMed ID: 12133538
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
[TBL] [Abstract][Full Text] [Related]
7. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
8. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.
Rogolino A; Coccia ME; Fedi S; Gori AM; Cellai AP; Scarselli GF; Prisco D; Abbate R
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):277-82. PubMed ID: 12695751
[TBL] [Abstract][Full Text] [Related]
9. Changes of serum thymidine kinase in children with acute leukemia.
Votava T; Topolcan O; Holubec L; Cerna Z; Sasek L; Finek J; Kormunda S
Anticancer Res; 2007; 27(4A):1925-8. PubMed ID: 17649797
[TBL] [Abstract][Full Text] [Related]
10. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
[TBL] [Abstract][Full Text] [Related]
12. [Study of fibrinolysis inhibitors in 117 acute leukemia patients].
Wang W; Ji CY; Ye JJ; Zhu YY; Guo DM; Ji M
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):183-6. PubMed ID: 18788619
[TBL] [Abstract][Full Text] [Related]
13. [Levels of plasma TF and TFPI activities in patients with acute leukemia].
Zhu Y; Xie ZX; He XF; Han JZ; Li JC; He SL
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):401-2, 405. PubMed ID: 12206017
[TBL] [Abstract][Full Text] [Related]
14. [Hemostatic variations associated with acute leukemia: clinical and prognostic significance].
Zhao W; Wang X; Qu B; Hu J; Sheng Z; Wang H
Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):469-71. PubMed ID: 11877021
[TBL] [Abstract][Full Text] [Related]
15. [The changes in molecular markers for hemostatic activation after t-PA therapy in case of pulmonary embolism].
Masuoka H; Hiraoka N; Inden M; Fujioka H; Konishi T; Nakano T; Deguchi K
Kokyu To Junkan; 1992 Apr; 40(4):407-10. PubMed ID: 1315073
[TBL] [Abstract][Full Text] [Related]
16. [Tissue factor (TF) and inhibitor (TFPI) concentrations in patients with urinary tract tumors and haematological malignancies].
Radziwon P; Schenk JF; Mazgajska K; Boczkowska-Radziwon B; Galar M; Kłoczko J; Wojtukiewicz MZ
Pol Merkur Lekarski; 2002 Oct; 13(76):308-11. PubMed ID: 12557438
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
Gori AM; Pepe G; Attanasio M; Falciani M; Abbate R; Prisco D; Fedi S; Giusti B; Brunelli T; Giusti B; Brunelli T; Comeglio P; Gensini GF; Neri Serneri GG
Thromb Haemost; 1999 Apr; 81(4):589-93. PubMed ID: 10235445
[TBL] [Abstract][Full Text] [Related]
18. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of markers of thrombin generation in the acute and chronic phases of non cardioembolic ischemic stroke.
Soncini M; Gasparini P; Lorena M; Motta A; Cimminiello C
Minerva Cardioangiol; 2000 Nov; 48(11):349-56. PubMed ID: 11214426
[TBL] [Abstract][Full Text] [Related]
20. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
Wada H; Sakuragawa N; Shiku H
Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
